{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:26:53Z","timestamp":1757453213672},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7455","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T18:16:18Z","timestamp":1490984178000},"page":"805-810","source":"Crossref","is-referenced-by-count":6,"title":["The Resection of Thyroid Cancer Was Associated with the Resolution of Hyporesponsiveness to an Erythropoiesis-stimulating Agent in a Hemodialysis Patient with Aceruloplasminemia"],"prefix":"10.2169","volume":"56","author":[{"given":"Soichiro","family":"Nagata","sequence":"first","affiliation":[{"name":"Department of Medicine, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ikegaya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Itaya","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoi","family":"Momita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Shinozaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ohura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kuriki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kono","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyajima","sequence":"additional","affiliation":[{"name":"First Department of Medicine, Hamamatsu University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Yaizu City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a combined phase I and phase II clinical trial. N Engl J Med 316: 73-78, 1987.","DOI":"10.1056\/NEJM198701083160203"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tsubakihara Y, Nishi S, Akiba T, et al. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial 14: 240-275, 2010.","DOI":"10.1111\/j.1744-9987.2010.00836.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Locatelli F, Aljama P, B\u00e1r\u00e1ny P, et al.; European Best Practice Guidelines Working Group. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol Dial Transplant 19 (Suppl 2): ii1-ii47, 2004.","DOI":"10.1093\/ndt\/gfh1031"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dicato M, Plawny L, Diederich M. Aneima in cancer. Ann Oncol 21 (Suppl 7): vii167-vii172, 2010.","DOI":"10.1093\/annonc\/mdq284"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pavese I, Satta F, Todi F, et al. High serum levels of TNF-\u03b1 and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients. Ann Oncol 21: 1523-1528, 2010.","DOI":"10.1093\/annonc\/mdp568"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Smrzova J, Jozsef Balla J, B\u00e1r\u00e1ny P. Inflammation and resistance to erythropoiesis-stimulating agents: what do we know and what needs to be clarified? Nephrol Dial Transplant 20 (Suppl 8): viii2-viii7, 2005.","DOI":"10.1093\/ndt\/gfh1109"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 150: 621-624, 1990.","DOI":"10.1001\/archinte.1990.00390150107020"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kono S, Suzuki H, Takahashi K, et al. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. Gastroenterology 131: 240-245, 2006.","DOI":"10.1053\/j.gastro.2006.04.017"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37: 761-767, 1987.","DOI":"10.1212\/WNL.37.5.761"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Miyajima H. Aceruloplasminemia. Neuropathol 35: 83-90, 2015.","DOI":"10.1111\/neup.12149"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kaneko Y, Miyajima H, Piperno A, et al. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders. J Gastroenterol 45: 1163-1171, 2010.","DOI":"10.1007\/s00535-010-0259-8"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Kitayama J, Osada T, Hamaguchi M, et al. A case report of hepatic abscess due to <i>Yersinia entercolitica<\/i> associated with hemosiderosis. The Japanese Journal of Gastroenterological Surgery 21: 2603-2606, 1988 (in Japanese).","DOI":"10.5833\/jjgs.21.2603"},{"key":"13","unstructured":"13. Miyajima H. Aceruloplasminemia. Pagon RA, Adam MP, Ardinger HH, et al., Eds. GeneReviews<sup>\u00ae<\/sup> [Internet]. 2003 Aug 12; Updated 2015 Nov 5. University of Washington, Seattle. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1493\/."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32: 107-114, 1998.","DOI":"10.1053\/ajkd.1998.v32.pm9669431"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29: 658-668, 1997.","DOI":"10.1016\/S0272-6386(97)90117-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Deugnier Y, Turlin B. Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 6: 491-494, 2001.","DOI":"10.1046\/j.1440-1746.2001.02430.x"},{"key":"17","unstructured":"17. Geier D, Hebert B, Potti A. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis. Anticancer Res 22: 3797-3799, 2002."},{"key":"18","unstructured":"18. De Sanctis V, Campisi S, Fiscina B, Soliman A. Papillary thyroid microcarcinoma in thalassaemia: an emerging concern for physicians? Georgian Med News 210: 71-76, 2012."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Poggi M, Sorrentino F, Pascucci C, et al. Malignancies in \u03b2-thalassemia patients: first description of two cases of thyroid cancer and review of the literature. Hemoglobin 35: 439-446, 2011.","DOI":"10.3109\/03630269.2011.588355"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/7\/56_56.7455\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:45:10Z","timestamp":1568972710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/7\/56_56.7455\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7455","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}